Roivant Sciences (ROIV) Total Debt (2021 - 2024)

Roivant Sciences' Total Debt history runs 4 years deep, the most recent figure standing at $323.7 million for Q2 2024.

• Quarterly Total Debt fell 17.51% year-over-year to $323.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $323.7 million (down 17.51% YoY) and the FY2024 annual result came in at $442.6 million, up 6.33% from the prior year.
• Total Debt was $323.7 million for Q2 2024 at Roivant Sciences, down from $442.6 million in the prior quarter.
• Across five years, Total Debt topped out at $442.6 million in Q1 2024 and bottomed at $170.3 million in Q1 2021.
• A 4-year average of $327.7 million and a median of $390.9 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt soared 109.85% — and 2024, when it retreated 17.51%.
• Roivant Sciences' Total Debt stood at $204.0 million in 2021, then jumped by 94.64% to $397.2 million in 2022, then climbed by 7.1% to $425.4 million in 2023, then decreased by 23.9% to $323.7 million in 2024.
• Business Quant data shows ROIV's Total Debt at $323.7 million in Q2 2024, $442.6 million in Q1 2024, and $425.4 million in Q4 2023.